These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17196702)

  • 41. Quality of ceftriaxone in Pakistan: reality and resonance.
    Obaid A
    Pak J Pharm Sci; 2009 Apr; 22(2):220-9. PubMed ID: 19339236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A survey of the quality of generic clarithromycin products manufactured in Slovenia and Israel.
    Nightingale CH
    Adv Ther; 2000; 17(3):167-78. PubMed ID: 11183454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reassurance about bioequivalence of generic thyroxine.
    Feek CM
    N Z Med J; 1992 Jan; 105(926):21. PubMed ID: 1549275
    [No Abstract]   [Full Text] [Related]  

  • 44. Debate: Substitution of generic drugs in epilepsy: is there cause for concern?
    Gidal BE; Tomson T
    Epilepsia; 2008 Dec; 49 Suppl 9():56-62. PubMed ID: 19087118
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biosimilars in clinical practice.
    Mikhail A
    Kidney Blood Press Res; 2007; 30 Suppl 1():18-22. PubMed ID: 17726339
    [No Abstract]   [Full Text] [Related]  

  • 46. [Medical problems and risks of switching drugs according to legal requirements of drug discount contracts in Germany].
    Pruszydlo MG; Quinzler R; Kaltschmidt J; Haefeli WE
    Dtsch Med Wochenschr; 2008 Jul; 133(27):1423-8. PubMed ID: 18592450
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Generic anti-arrhythmic drugs.
    Obel IW
    Cardiovasc J S Afr; 2002; 13(3):131; author reply 132-3. PubMed ID: 12193966
    [No Abstract]   [Full Text] [Related]  

  • 48. [Original or generic?].
    Magyar IG
    Neuropsychopharmacol Hung; 2005 Dec; 7(4):167-8. PubMed ID: 16496480
    [No Abstract]   [Full Text] [Related]  

  • 49. [Generic antiarrhythmics: safety and efficacy versus cost].
    Katz A; Zalzstein E
    Harefuah; 2001 Nov; 140(11):1087-90. PubMed ID: 11759388
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmaceutical impurities: analytical, toxicological and regulatory perspectives.
    Basak AK; Raw AS; Yu LX
    Adv Drug Deliv Rev; 2007 Jan; 59(1):1-2. PubMed ID: 17196297
    [No Abstract]   [Full Text] [Related]  

  • 51. Generic substitution of pharmaceuticals.
    Bollen M
    Aust Fam Physician; 1994 Dec; 23(12):2254-5. PubMed ID: 7848139
    [No Abstract]   [Full Text] [Related]  

  • 52. Development and validation of HPLC method for the determination of Cyclosporin A and its impurities in Neoral capsules and its generic versions.
    Bonifacio FN; Giocanti M; Reynier JP; Lacarelle B; Nicolay A
    J Pharm Biomed Anal; 2009 Feb; 49(2):540-6. PubMed ID: 19124213
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current status of the international comparator (reference) product system.
    Idänpään-Heikkilä JE
    Eur J Drug Metab Pharmacokinet; 2000; 25(1):36-7. PubMed ID: 11032088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy.
    Liow K; Barkley GL; Pollard JR; Harden CL; Bazil CW;
    Neurology; 2007 Apr; 68(16):1249-50. PubMed ID: 17438213
    [No Abstract]   [Full Text] [Related]  

  • 55. Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures.
    Berg MJ; Gross RA; Tomaszewski KJ; Zingaro WM; Haskins LS
    Neurology; 2008 Aug; 71(7):525-30. PubMed ID: 18695164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmaceutical impurities--a mini-review.
    Roy J
    AAPS PharmSciTech; 2002; 3(2):E6. PubMed ID: 12916943
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Basic facts about biosimilars.
    Nowicki M
    Kidney Blood Press Res; 2007; 30(5):267-72. PubMed ID: 17622764
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Generics in psychiatry--do they have the same therapeutic equivalence as the original?].
    Kasper S; Lentner S
    Neuropsychiatr; 2008; 22(4):221-2. PubMed ID: 19080992
    [No Abstract]   [Full Text] [Related]  

  • 59. [Special generic drugs in Spain].
    Carné X; Díez Rodrigálvarez M; García-Alonso F
    Med Clin (Barc); 1999 Mar; 112(9):337-9. PubMed ID: 10220766
    [No Abstract]   [Full Text] [Related]  

  • 60. EMEA guidelines on biosimilars and their clinical implications.
    Rossert J
    Kidney Blood Press Res; 2007; 30 Suppl 1():13-7. PubMed ID: 17726338
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.